GBA1 and Parkinson disease: In this LFP pilot study, the peak beta ratio in GBA mutation carriers with PD was more asymmetric compared with non-mutation carriers and this corresponded to the degree of clinical asymmetry as measured by the bradykinesia-rigidity asymmetry score.